Sansure Biotech Inc. (688289.SS) SHH

21.93

-0.1(-0.45%)

Updated at August 19 02:20PM

Currency In CNY

Valuation

Market Cap13.36B
Enterprise Value9.19B
P/E Ratio41.87
PEG Ratio9.21
Price/Sales Ratio7.95
Price/Book Ratio1.72
Enterprise/Revenue5.7
Enterprise/EBITDA27.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.19
Operating Margin0.13

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue1.46B
Revenue/Share2.75
Gross Profit1.14B
EBITDA430.48M
Net Income275.6M
Diluted EPS0.44

Balance Sheet

Total Cash4.5B
Total Cash/Share7.85
Total Debt839.6M
Total Debt/Equity0.11
Current Ratio4.44
Book Value Per Share12.96

Price History

52-Week Change14.24
52-Week High26.36
52-Week Low16.44
Moving Average 50 Days21.16
Moving Average 200 Days21.49

Statistics

Average Volume6.24M
Shares Outstanding569.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.53
Trailing Annual Dividend Yield2.38
Payout Ratio0.91
Last Split Factor37:25
Last Split DateJune 01, 2022